Intended Use

The Cerebral Autoregulation Index (CAI) Algorithm is intended to represent a surrogate measurement of whether cerebral autoregulation is likely intact or impaired by analyzing coherence between Mean Arterial Pressure (MAP) and absolute cerebral blood oxygen saturation (StO2) in patients over 18 years receiving advanced hemodynamic monitoring.

Technology

The CAI Algorithm calculates the level of coherence between cerebral tissue oxygen saturation measured by near-infrared spectroscopy (NIRS) signals and mean arterial pressure (MAP) signals. It outputs an index value between 0 to 100 shown in trend plots at a 20-second update rate. The device combines data from FDA cleared cerebral oximeter cables (ForeSight) and pressure cables (HemoSphere). No alarms are provided, the index informs clinicians of cerebral autoregulation status.

Performance

Performance testing included software verification per IEC 62304 and FDA guidance, using animal and clinical data; clinical validation was performed on 50 adult subjects undergoing surgery at multiple sites. The ROC AUC was 0.92 with sensitivity 82% and specificity 94% at the CAI threshold of 45, demonstrating effective discrimination of impaired versus intact cerebral autoregulation across sites.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    3/4/2024

    7 months
  • 2

    FDA Approval

    10/16/2024

Other devices from Edwards Lifesciences

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.